← USANA HEALTH SCIENCES INC
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.0b | $1.2b | $1.1b | $1.1b | $1.1b | $998.6m | $921.0m | $854.5m | $925.3m | $925.3m | |
| Cost of Revenue | $179.4m | $200.7m | $187.5m | $209.1m | $209.1m | $193.9m | $176.7m | $161.2m | $200.9m | $200.9m | |
| Cost of sales | $179.4m | $200.7m | $187.5m | — | $209.1m | $217.9m | $176.7m | $161.2m | — | $200.9m | |
| Gross Profit | $867.9m | $988.5m | $873.4m | $925.5m | $925.5m | $804.7m | $744.3m | $693.3m | $724.4m | $724.4m | |
| Selling, general and administrative | $265.1m | $275.1m | $267.7m | — | $261.2m | $279.1m | $257.0m | $263.3m | — | $337.4m | |
| Operating Expenses | $735.4m | $800.2m | $727.2m | $749.0m | — | $697.1m | $651.2m | $627.0m | $687.0m | — | |
| Total operating expenses | $735.4m | $800.2m | $727.2m | — | $749.0m | $798.4m | $651.2m | $627.0m | — | $687.0m | |
| Operating Income (Loss) | $132.5m | $188.4m | $146.2m | $176.5m | — | $107.6m | $93.1m | $66.3m | $37.4m | — | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $1.5m | $1.5m | $1.4m | $1.3m | — | $1.7m | $1.8m | $1.5m | $19.3m | — | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | $0 | — | $0 | $0 | $0 | $0 | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | — | $0 | $0 | $0 | $6.5m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | $1.5m | $111k | $18.8m | — | ($24.0m) | ($20.0m) | ($35.3m) | ($56.2m) | — | |
| Other Income | — | — | — | $3.8m | — | $3.5m | $3.2m | $2.4m | $2.3m | — | |
| Brand Partner incentives | — | — | — | — | — | — | $394.3m | $363.7m | — | $336.2m | |
| Impairment | — | — | — | — | — | — | $0 | $0 | — | $7.0m | |
| Earnings from operations | $132.5m | $188.4m | $146.2m | — | $176.5m | $170.2m | $93.1m | $66.3m | — | $37.4m | |
| Interest income | $2.2m | $4.4m | $4.7m | — | $2.5m | $2.5m | $9.6m | $11.3m | — | $2.4m | |
| Other, net | ($3k) | ($1.2m) | ($335k) | — | ($571k) | ($2.0m) | $7k | ($1.0m) | — | $2.5m | |
| Earnings before income taxes | $134.6m | $191.5m | $150.5m | — | $177.9m | $170.6m | $102.5m | $76.4m | — | $41.5m | |
| Income taxes | $72.1m | $65.3m | $50.0m | — | $53.3m | $54.1m | $38.7m | $34.3m | — | $30.1m | |
| Net earnings | $62.5m | $126.2m | $100.5m | $124.7m | — | $69.3m | $63.8m | $42.1m | $10.8m | $11.5m | |
| Less: Net earnings attributable to redeemable noncontrolling interest | — | — | — | — | — | $0 | $0 | $30k | — | $717k | |
| Net earnings attributable to USANA | $62.5m | $126.2m | $100.5m | — | $124.7m | $116.5m | $63.8m | $42.0m | — | $10.8m | |
| Basic (in shares) | $24.3m | $24.1m | $22.6m | — | $21.2m | $20.1m | $19.2m | $19.1m | — | $18.5m | |
| Diluted (in shares) | $24.7m | $24.6m | $22.8m | — | $21.3m | $20.3m | $19.3m | $19.2m | — | $18.6m | |
| Foreign currency translation adjustment | $15.0m | ($10.9m) | ($2.7m) | — | $13.3m | $2.2m | ($1.3m) | ($9.4m) | — | $7.2m | |
| Other comprehensive income (loss), net of tax | $10.2m | ($9.0m) | ($3.5m) | — | $10.3m | $4.1m | ($908k) | ($9.0m) | — | $6.5m | |
| Comprehensive income | — | — | — | — | — | $56.1m | $62.9m | $33.1m | — | $18.0m | |
| Less: comprehensive income attributable to redeemable noncontrolling interest | — | — | — | — | — | $0 | $0 | $30k | — | $717k | |
| Comprehensive income attributable to USANA | $72.8m | $117.3m | $97.0m | — | $134.9m | $120.6m | $62.9m | $33.1m | — | $17.3m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | $108.6m | $102.5m | $76.4m | $41.5m | — | |
| Net Income (Loss) Attributable to Parent | $62.5m | $126.2m | $100.5m | $124.7m | — | $69.3m | $63.8m | $42.0m | $10.8m | $11.5m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $62.5m | $126.2m | $100.5m | $124.7m | — | $69.3m | $63.8m | $42.1m | $10.8m | $11.5m | |
| Earnings Per Share, Basic | $2.57 | $5.24 | $4.44 | $5.89 | $5.89 | $3.60 | $3.31 | $2.20 | $0.58 | $0.58 | |
| Earnings Per Share, Diluted | $2.53 | $5.12 | $4.41 | $5.86 | $5.86 | $3.59 | $3.30 | $2.19 | $0.58 | $0.58 | |
| Weighted Average Number of Shares Outstanding, Basic | 24.3m | 24.1m | 22.6m | 21.2m | — | 19.3m | 19.2m | 19.1m | 18.5m | — | |
| Weighted Average Number of Shares Outstanding, Diluted | 24.7m | 24.6m | 22.8m | 21.3m | — | 19.3m | 19.3m | 19.2m | 18.6m | — | |
| Research and Development Expense | $9.0m | $10.2m | $10.3m | $10.6m | — | $11.6m | $11.4m | $11.6m | $10.7m | — | |
| Selling, General and Administrative Expense | $265.1m | $275.1m | $267.7m | $261.2m | — | $262.3m | $257.0m | $263.3m | $337.4m | — | |
| Other Nonoperating Income (Expense) | ($3k) | ($1.2m) | ($335k) | ($571k) | — | ($2.6m) | $7k | ($1.0m) | $2.5m | — | |
| Operating Lease, Expense | — | — | $9.6m | $11.2m | — | $8.3m | $8.8m | $8.2m | $8.3m | — | |
| Cost realignment | — | — | — | — | — | — | $0 | $0 | — | $6.5m | |
| Other income (expense), net | $2.1m | $3.2m | $4.3m | — | $1.5m | $450k | $9.4m | $10.0m | — | $4.1m | |
| Tax benefit (expense) related to foreign currency translation adjustment | ($4.8m) | $1.9m | ($778k) | — | ($3.1m) | $1.9m | $390k | $434k | — | ($658k) | |
| Interest Expense (non-operating) | — | — | — | — | — | — | $262k | $281k | $842k | — | |
| Interest Expense | $46k | $36k | $66k | $507k | ($507k) | $192k | $262k | ($281k) | — | ($842k) | |
| Current Income Tax Expense (Benefit) | $51.6m | $64.7m | $53.6m | $55.8m | — | $46.2m | $41.3m | $41.0m | $37.2m | — | |
| Income Tax Expense (Benefit) | $72.1m | $65.3m | $50.0m | $53.3m | — | $39.3m | $38.7m | $34.3m | $30.1m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.